Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MTP Midatech Pharma > Detailed Quotes

MTP Midatech Pharma

1.940
+0.080+4.30%
Close 10/03 16:00 ET
High
1.995
Open
1.900
Turnover
31.79K
Low
1.840
Pre Close
1.860
Volume
16.53K
Market Cap
7.64M
P/E(TTM)
Loss
52wk High
9.550
Shares
3.94M
P/E(Static)
Loss
52wk Low
1.840
Float Cap
6.63M
Bid/Ask %
-33.33%
Historical High
1835.000
Shs Float
3.42M
Volume Ratio
0.31
Historical Low
1.840
Dividend TTM
--
Div Yield TTM
--
P/B
0.96
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.48%
Amplitude
8.33%
Avg Price
1.923
Lot Size
1
Float Cap
6.63M
Bid/Ask %
-33.33%
Historical High
1835.000
Shs Float
3.42M
Volume Ratio
0.31
Historical Low
1.840
Dividend TTM
--
P/B
0.96
Dividend LFY
--
Turnover Ratio
0.48%
Amplitude
8.33%
Avg Price
1.923
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Midatech Pharma Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
CEO: Mr. Stephen Anthony Stamp
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...